... (3)dibutylphthalate, (4) bis(3-tert-butyl-6-hydroxy-methylphenyl)-methane, (5)dioctylphthalate, (6) pentaerytritol-tetrakis, (7) trimethyl-2 ,4, 6-tris(3,5-di-tert-butyl -4 - hydroxybenzyl)-benzene(1,3, 5-) , (8) ... trimethyl-2 ,4, 6-tris(3,5-di-tert-butyl -4 - hydroxybenzyl)-benzene(1,3, 5-) , (8) octadecyl- 3-( 3,5-di-tert-butyl- 4- hydroxyphenyl)-propionate, (9) tris(2 , 4- tert-butyl-phenyl)-phosphite. Themethod consists of a C18 column with premixed ... %Impurity %Assay %Impurity MassActive (Salt) 100 99 .8 0.1 0.03 0 99 .9 Placebo None detectedFormulation 97 .9 94 .9 1 0.6 0.03 96 .5Blendwith Active (Salt)formulation development is to ensure that...